ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 82 filers reported holding ENZO BIOCHEM INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,387,000 | +11.1% | 170,144 | +42.7% | 1.33% | +13.7% |
| Q3 2017 | $1,248,000 | -2.4% | 119,238 | +2.9% | 1.17% | -3.2% |
| Q2 2017 | $1,279,000 | +1.8% | 115,878 | -22.7% | 1.21% | -5.1% |
| Q1 2017 | $1,256,000 | +59.4% | 150,000 | +13.7% | 1.28% | -0.7% |
| Q2 2016 | $788,000 | -59.3% | 131,956 | -69.0% | 1.28% | -51.8% |
| Q1 2016 | $1,937,000 | -18.4% | 425,762 | -19.3% | 2.67% | +7.5% |
| Q4 2015 | $2,373,000 | +13.5% | 527,274 | -20.1% | 2.48% | +10.4% |
| Q3 2015 | $2,091,000 | +36.5% | 659,511 | +30.4% | 2.25% | +40.7% |
| Q2 2015 | $1,532,000 | – | 505,583 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
| Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
| Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
| CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
| Fondren Management LP | 175,863 | $593,000 | 0.56% |
| MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
| EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
| Leap Investments LP | 11,811 | $40,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |